Health Highlights: Oct. 4, 2012

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Generic Antidepressant Pulled From Market

A generic version of the popular antidepressant Wellbutrin is being taken off the market after a U.S. Food and Drug Administration analysis showed that it does not work properly.

FDA tests found that the generic drug Budeprion XL 300 released its key ingredient into the blood faster than the brand name drug. The FDA told Teva Pharmaceuticals to withdraw its generic drug, the AP reported.

In 2008, the FDA issued an update that said Budeprion XL 300 and Wellbutrin were essentially the same. That review was conducted after hundreds of patients complained that the generic drug was ineffective or caused side effects such as anxiety, insomnia and headaches.

The FDA's own study of the generic and brand name drug was completed in August, the AP reported.

Copyright © 2012 HealthDay. All rights reserved.

HealthDay news articles are derived from various sources and do not reflect federal policy. Womenshealth.gov does not endorse opinions, products, or services that may appear in news stories.

Return to top

womenshealth.gov
A federal government website managed by the Office on Women's Health in the Office of the Assistant Secretary for Health at the U.S. Department of Health and Human Services.
200 Independence Avenue, S.W. • Washington, DC 20201